which was, on the 23rd day of May 2003, registered as foreign company under section 332 (1) of the Companies Act 1965, did on the 25th day of August 2021 change its name to POLYONE SINGAPORE PTE. This certificate is generated from MYDATA SSM Services as at 31/08/2021 12:30:12 1 1/ Date: Tue Aug 31 12:30:12 2021 Printing Date: 31/08/2021User Id: mooileen

www.fojas.cl Pag: 1/1 Pag: 1/11 Pag: 2/11 Pag: 3/11 Pag: 4/11 Pag: 5/11 Pag: 6/11 Pag: 7/11 Pag: 8/11 Pag: 9/11 Pag: 10/11 Pag: 11/11 2021-05-31T12:52:48-0400 Santiago - Chile EDUARDO JAVIER DIEZ MORELLO Notario Publico Eduardo_Diez_Morello

Eastern Time Record Date Voting Matters and Vote Recommendations Proposals For Your Vote Board Recommendation 1 2 3 4 Lisa K. 1) Adjusted EPS reported in this proxy statement differs from what is reported under United States GAAP. Kunkle, Senior Vice President, General Counsel and Secretary(1) Joel R.

$1.74 $1.93 $2.80 2019PF 2020PF 2021E Adjusted EPS (1) + 61% (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 4 Webcast Details The webcast can be viewed live at avient.com/investors, or by clicking here: https://edge.media- server.com/mmc/p/eaivs28r. To participate in the audio-only portion of the call, dial 1-844-835- 7433 (domestic) or 1-914-495-8589 (international) and provide conference ID number 6746706. To access, dial 1-855-859-2056 (domestic) or 1-404-537-3406 (international) and provide conference ID number 6746706.

Mold Design Recommendations Gates 1. Avoid gating into thin part region Runners 1. Hot runner molds are acceptable and should be sized by the manufacturer Cold Slug Wells 1.

ECert - 2023-09-26T122339.151.pdf Page 1 of 10 Validity of this certificate is based on the successful completion of the periodic surveillance audits of the management system defined by the above scope and is contingent upon prompt,written notification to ABS Quality Evaluations, Inc. of significant changes to the management system or components thereof. Kalisabi No. 1, Kec. No: 149/1 Gebze, Kocaeli 41400 Turkey Facility: Avient Turkey Renklendirici ve Katkı Maddeleri Sanayi ve Ticaret A 5.

A 1:1 wall thickness will produce sink and cause stress where the ribs connect with the main wall. Draft on the outside of the boss should be 1°. FIGURE 16 - Structural hole design guidelines FIGURE 15 - Through-hole shapes ENDNOTES 1 Jansen, J.

Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and has a pending sale of the Distribution segment. To provide comparable results, the company references “pro forma” financial metrics, which include the business results of Avient Protective Materials for periods prior to the Acquisition Date, as if the transaction occurred on January 1, 2021 and reflect Distribution as a discontinued operation. Additionally, Adjusted EPS excludes the impact of special items and amortization expense associated with intangible assets. 2 PRO FORMA 2021 TO 2022 BRIDGE 3 2021 EPS from Continuing Operations 1.69$ Pro Forma & Special Items 1.33 Proforma 2021 Adjusted EPS 3.02$ FX Impact (0.22) China Lockdowns / Russia Import Sales (0.24) Outdoor High Performance (0.13) Dyneema 0.06 Color, Additives and Inks 0.38 Legacy Specialty Engineered Materials 0.22 Other 0.01 Proforma 2022 Adjusted EPS 3.10$ COLOR, ADDITIVES AND INKS 7% (4%) (9%) 6% (10%) 0% 1% 2% 7% 10% 4% (3%) 12% (6%) 5% 6% 9% 610 650 624 649 587 565 581 526 2,402 2,390 589 650 589 649 543 565 545 526 2,266 2,390 116 121 112 119 93 95 88 79 409 414 113 121 106 119 87 95 84 79 390 414 10% 4 (1%) PRO FORMA SPECIALTY ENGINEERED MATERIALS 16%8% (8%) (8%) 3% (6%) (6%) (2%) 2% 20%12% (1%) (2%) 5% (1%) (2%) 3% 6% 314 338 348 343 325 300 321 295 1,308 1,276 303 338 329 343 303 300 301 295 1,236 1,276 67 78 75 77 70 66 66 62 278 283 65 78 73 77 67 66 63 62 268 283 5 Constant Currency Adjusted EPS Adjusted EPS PRO FORMA AVIENT 10% (3%) (21%) 3% 9% 5% 7% (5%) (9%) (1%) (1%) (12%) 1% 17% 8% (14%) 11% 14% 10% 11% 2% (3%) 5% 8% (5%) 7% 925 987 973 992 912 867 902 823 3,712 3,669 893 987 919 992 847 867 845 823 3,504 3,669 161 176 164 172 142 141 133 117 600 606 155 176 157 172 131 141 123 117 566 6068% 2% 0.84 0.98 0.87 0.96 0.70 0.68 0.61 0.48 3.02 3.10 0.79 0.98 0.82 0.96 0.63 0.68 0.56 0.48 2.80 3.10 17% 24% 6 March 31, 2022 March 31, 2021 Net income from continuing operations $ 64.7 $ 60.4 Net income attributable to noncontrolling interests (0.3) (0.4) Net income from continuing operations attributable to Avient shareholders $ 64.4 $ 0.70 $ 60.0 $ 0.65 Special items, after tax $ 6.4 $ 0.07 $ 2.6 $ 0.03 APM pro forma adjustments 2.6 0.03 (3.1) (0.03) Amortization expense, after tax 17.4 0.19 17.9 0.19 Adjusted pro forma net income / EPS $ 90.8 $ 0.98 $ 77.4 $ 0.84 Weighted average diluted shares 92.3 92.2 June 30, 2022 June 30, 2021 Net income from continuing operations $ 62.8 $ 50.2 Net income attributable to noncontrolling interests — (0.6) Net income from continuing operations attributable to Avient shareholders $ 62.8 $ 0.68 $ 49.6 $ 0.54 Special items, after tax $ 3.2 $ 0.03 $ 11.7 $ 0.13 APM pro forma adjustments 5.2 0.06 1.4 0.02 Amortization expense, after tax 17.2 0.19 17.8 0.19 Adjusted pro forma net income / EPS $ 88.4 $ 0.96 $ 80.5 $ 0.87 Weighted average diluted shares 92.1 92.4 September 30, 2021 Reconciliation to Condensed Consolidated Statements of Income Avient EPS Net income from continuing operations $ 33.4 Net income attributable to noncontrolling interests 0.3 Net income from continuing operations attributable to Avient shareholders $ 33.7 $ 0.37 Special items, after tax $ 11.7 $ 0.13 APM pro forma adjustments 1.5 0.02 Amortization expense, after tax 17.6 0.19 Adjusted pro forma net income / EPS $ 64.5 $ 0.70 Weighted average diluted shares 92.2 Adjusted EPS may not recalculate due to rounding. 1 December 31, 2021 Year Ended December 31, 2021 Net income from continuing operations $ 11.2 $ 155.2 Net income attributable to noncontrolling interests 0.9 0.2 Net income from continuing operations attributable to Avient shareholders $ 12.1 $ 0.13 $ 155.4 $ 1.69 Special items, after tax $ 24.0 $ 0.26 $ 50.0 $ 0.54 APM pro forma adjustments 2.5 0.03 1.6 0.02 Amortization expense, after tax 17.8 0.19 71.1 0.77 Adjusted pro forma net income / EPS $ 56.4 $ 0.61 $ 278.1 $ 3.02 Weighted average diluted shares 92.4 92.1 Reconciliation of Color, Additives and Inks EBITDA Operating Income 88.8 86.3 66.8 61.2 303.1 94.5 93.6 Depreciation and amortization 27.4 25.3 26.6 26.4 105.7 26.0 25.9 EBITDA $ 116.2 $ 111.6 $ 93.4 $ 87.6 $ 408.8 $ 120.5 $ 119.5 Q1 2021 Q2 2021 Q3 2021 Pro forma Pro forma Pro forma Pro forma Pro forma Pro forma Operating Income 32.6 9.1 41.7 35.8 13.9 49.7 30.0 15.2 45.2 Depreciation and amortization 7.8 17.5 25.3 8.1 17.3 25.4 7.9 17.1 25.0 EBITDA $ 40.4 $ 26.6 $ 67.0 $ 43.9 $ 31.2 $ 75.1 $ 37.9 $ 32.3 $ 70.2 Q4 2021 YTD 2021 Pro forma Pro forma Pro forma Pro forma Operating Income 27.1 11.7 38.8 125.5 49.9 175.4 Depreciation and amortization 8.0 18.9 26.9 31.8 70.8 102.6 EBITDA $ 35.1 $ 30.6 $ 65.7 $ 157.3 $ 120.7 $ 278.0 2 Q1 2022 Q2 2022 Pro forma Pro forma Pro forma Pro forma Operating Income 38.3 15.4 53.7 35.2 17.7 52.9 Depreciation and amortization 7.8 16.6 24.4 7.7 16.6 24.3 EBITDA $ 46.1 $ 32.0 $ 78.1 $ 42.9 $ 34.3 $ 77.2 Q1 2021 Q2 2021 Q3 2021 Pro forma Pro forma Pro forma Pro forma Pro forma Pro forma Net income from continuing operations 60.4 (3.1) 57.3 50.2 1.4 51.6 33.4 1.5 34.9 Income tax expense 16.3 1.1 17.4 13.8 1.3 15.1 2.0 2.5 4.5 Interest expense 19.3 11.1 30.4 19.5 11.2 30.7 19.0 11.2 30.2 Depreciation and amortization 36.9 17.5 54.4 33.6 17.3 50.9 36.6 17.1 53.7 EBITDA 132.9 26.6 159.5 117.1 31.2 148.3 91.0 32.3 123.3 Special items, before tax 2.4 — 2.4 14.2 — 14.2 19.9 — 19.9 Depreciation included in special items (0.6) — (0.6) 1.4 — 1.4 (0.9) — (0.9) Adjusted EBITDA $ 134.7 $ 26.6 $ 161.3 $ 132.7 $ 31.2 $ 163.9 $ 110.0 $ 32.3 $ 142.3 Q4 2021 YTD 2021 Pro forma Pro forma Pro forma Pro forma Net income from continuing operations 11.2 2.5 13.7 155.2 1.6 156.8 Income tax expense 16.2 (1.9) 14.3 48.3 3.7 52.0 Interest expense 17.5 11.1 28.6 75.3 44.6 119.9 Depreciation and amortization 37.9 18.9 56.8 145.0 70.8 215.8 EBITDA 82.8 30.6 113.4 423.8 120.7 544.5 Special items, before tax 20.6 — 20.6 57.1 — 57.1 Depreciation included in special items (1.6) — (1.6) (1.7) — (1.7) Adjusted EBITDA $ 101.8 $ 30.6 $ 132.4 $ 479.2 $ 120.7 $ 599.9 3 Q1 2022 Q2 2022 Pro forma Pro forma Pro forma Pro forma Net income from continuing operations 64.7 2.6 67.3 62.8 5.2 68.0 Income tax expense 20.0 1.7 21.7 22.7 1.4 24.1 Interest expense 16.9 11.1 28.0 16.2 11.1 27.3 Depreciation and amortization 37.6 16.6 54.2 36.3 16.6 52.9 EBITDA 139.2 32.0 171.2 138.0 34.3 172.3 Special items, before tax 6.6 — 6.6 0.9 — 0.9 Depreciation included in special items (2.1) — (2.1) (1.1) — (1.1) Adjusted EBITDA $ 143.7 $ 32.0 $ 175.7 $ 137.8 $ 34.3 $ 172.1 Reconciliation of Specialty Engineered Pro Forma Sales Sales 214.7 238.9 231.7 226.3 911.6 243.1 242.3 Pro forma APM 98.9 108.8 93.8 94.9 396.4 94.8 100.5 Pro forma sales $ 313.6 $ 347.7 $ 325.5 $ 321.2 $ 1,308.0 $ 337.9 $ 342.8 Reconciliation of Avient Pro Forma Sales Sales 826.0 864.5 818.0 807.1 3,315.6 892.2 891.0 Pro forma APM 98.9 108.8 93.8 94.9 396.4 94.8 100.5 Pro forma sales $ 924.9 $ 973.3 $ 911.8 $ 902.0 $ 3,712.0 $ 987.0 $ 991.5 4 IR Slides V17 - 9.26 324pm IR Deck - AVNT-2022.09.27 Pre Release v2

REFERENCES [1] S. Biotechnol. 2021, 9, 1. [27] R. Microbiol. 2019, 10, 1. [29] J.

All Rights Reserved 2025 Playbook in current environment 1. Executing flawlessly and continue advancing our strategy while prioritizing investments and resources for our growth vectors 1. 2. 3. 4. 5. 6. All Rights Reserved 2025 Color, Additives & Inks E N D M A R K E T S R E G I O N S 34% 21% 15% 11% 9% 8% Packaging Telecom 1%Energy 1% Transportation Industrial Consumer 34% 37% 20% 9% US & Canada Latin America Asia Europe, Middle East and Africa Healthcare Building & Construction 15Copyright © .